NCT02208050View on ClinicalTrials.gov

A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 21, 2014

Primary Completion Date

February 16, 2016

Study Completion Date

February 16, 2016

Conditions
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
Interventions
DRUG

Fampridine

DRUG

Placebo

Trial Locations (2)

Unknown

St Vincent's University Hospital, Dublin

D4

St. Vincents University Hospital, Dublin

All Listed Sponsors
lead

University College Dublin

OTHER

NCT02208050 - A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS | Biotech Hunter | Biotech Hunter